These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

229 related articles for article (PubMed ID: 27261537)

  • 21. The effect of dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY Trial (Randomized Evaluation of Long-Term Anticoagulation Therapy).
    Reilly PA; Lehr T; Haertter S; Connolly SJ; Yusuf S; Eikelboom JW; Ezekowitz MD; Nehmiz G; Wang S; Wallentin L;
    J Am Coll Cardiol; 2014 Feb; 63(4):321-8. PubMed ID: 24076487
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The assessment of anticoagulant activity to predict bleeding outcome in atrial fibrillation patients receiving dabigatran etexilate.
    Chang YT; Hu YF; Liao JN; Chern CM; Lin YJ; Chang SL; Wu CH; Sung SH; Wang KL; Lu TM; Chao TF; Lo LW; Hsu LC; Chung CP; Chang PM; Hsu WH; Chiou CW; Chen SA
    Blood Coagul Fibrinolysis; 2016 Jun; 27(4):389-95. PubMed ID: 26991859
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics/Pharmacodynamics of Dabigatran 75 mg Twice Daily in Patients With Nonvalvular Atrial Fibrillation and Severely Impaired Renal Function.
    Martin JL; Esmaeili H; Manuel RC; Petrini M; Wiebe S; Maas H
    J Cardiovasc Pharmacol Ther; 2018 Sep; 23(5):399-406. PubMed ID: 29695165
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Factors Affecting Trough Plasma Dabigatran Concentrations in Patients with Atrial Fibrillation and Chronic Kidney Disease.
    Skripka A; Sychev D; Bochkov P; Shevchenko R; Krupenin P; Kogay V; Listratov A; Krainyaya A; Gurinovich O; Sokolova A; Napalkov D; Fomin V
    High Blood Press Cardiovasc Prev; 2020 Apr; 27(2):151-156. PubMed ID: 32215878
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dosage Adjustment of Dabigatran Etexilate Based on Creatinine Clearance in Patients With Cardioembolic Stroke or Atrial Fibrillation.
    Matsuda S; Imazu T; Kimura R; Nakamura M; Matsumoto A; Murakami T; Maeda Y
    Ther Drug Monit; 2016 Dec; 38(6):670-676. PubMed ID: 27559839
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Impact of dabigatran on platelet function and fibrinolysis.
    Tsantes AE; Kyriakou E; Bonovas S; Chondrogianni M; Zompola C; Liantinioti C; Simitsi A; Katsanos AH; Atta M; Ikonomidis I; Kapsimali V; Kopterides P; Tsivgoulis G
    J Neurol Sci; 2015 Oct; 357(1-2):204-8. PubMed ID: 26219486
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of Oseltamivir Activation with Gender and Carboxylesterase 1 Genetic Polymorphisms.
    Shi J; Wang X; Eyler RF; Liang Y; Liu L; Mueller BA; Zhu HJ
    Basic Clin Pharmacol Toxicol; 2016 Dec; 119(6):555-561. PubMed ID: 27228223
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dagibatran Etexilate: Is There Any Need for Coagulation Monitoring After Initiation?
    Hoepner R; Behrendt V; Meves S; Gold R; Krogias C
    Neurologist; 2015 Jul; 20(1):1-3. PubMed ID: 26185953
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of Dabigatran on Clotting Time in the Clotpro Ecarin Clotting Assay: A Prospective, Single-Arm, Open-Label Study.
    Fong AYY; Tiong LL; Tan SSN; Geruka D; Apil GG; Choo CW; Ong TK
    Clin Appl Thromb Hemost; 2020; 26():1076029620972473. PubMed ID: 33284050
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of ABCB1 gene polymorphisms rs1128503, rs2032582, rs4148738 with anemia in patients receiving dabigatran after total knee arthroplasty.
    Kasimova A; Labutin D; Gvozdetsky A; Bozhkova S
    Chin J Traumatol; 2024 Jan; 27(1):27-33. PubMed ID: 37423837
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Influence of ABCB1 (rs1045642 and rs4148738) Gene Polymorphisms on Rivaroxaban Pharmacokinetics in Patients Aged 80 Years and Older with Nonvalvular Atrial Fibrillation.
    Sychev D; Ostroumova O; Cherniaeva M; Shakhgildian N; Mirzaev K; Abdullaev S; Denisenko N; Sozaeva Z; Kachanova A; Gorbatenkova S; Shastina V
    High Blood Press Cardiovasc Prev; 2022 Sep; 29(5):469-480. PubMed ID: 35960493
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The Influence of Structural Variants of the
    Ikonnikova A; Kazakov R; Rodina T; Dmitriev A; Melnikov E; Zasedatelev A; Nasedkina T
    Genes (Basel); 2022 Nov; 13(12):. PubMed ID: 36553492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Determination of dabigatran and rivaroxaban by ultra-performance liquid chromatography-tandem mass spectrometry and coagulation assays after major orthopaedic surgery.
    Schellings MW; Boonen K; Schmitz EM; Jonkers F; van den Heuvel DJ; Besselaar A; Hendriks JG; van de Kerkhof D
    Thromb Res; 2016 Mar; 139():128-34. PubMed ID: 26916310
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Thrombelastography detects dabigatran at therapeutic concentrations in vitro to the same extent as gold-standard tests.
    Solbeck S; Ostrowski SR; Stensballe J; Johansson PI
    Int J Cardiol; 2016 Apr; 208():14-8. PubMed ID: 26826624
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Real-Life Peak and Trough Dabigatran Plasma Measurements over Time in Hospitalized Geriatric Patients with Atrial Fibrillation.
    Chaussade E; Hanon O; Boully C; Labourée F; Caillard L; Gerotziafas G; Vidal JS; Elalamy I
    J Nutr Health Aging; 2018; 22(1):165-173. PubMed ID: 29300437
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Association between
    Li H; Zhang Z; Weng H; Qiu Y; Zubiaur P; Zhang Y; Fan G; Yang P; Vuorinen AL; Zuo X; Zhai Z; Wang C
    Front Cardiovasc Med; 2022; 9():959916. PubMed ID: 35990949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of Dabigatran Treatment on Rotation Thromboelastometry.
    Sokol J; Nehaj F; Ivankova J; Mokan M; Zolkova J; Lisa L; Linekova L; Mokan M; Stasko J
    Clin Appl Thromb Hemost; 2021; 27():1076029620983902. PubMed ID: 33523711
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic determinants of dabigatran safety (CES1 gene rs2244613 polymorphism) in the Russian population: multi-ethnic analysis.
    Sychev DA; Abdullaev SP; Mirzaev KB; Ryzhikova KA; Shuyev GN; Sozaeva ZA; Grishina EA; Mammaev SN; Gafurov DM; Kitaeva EY; Shprakh VV; Suleymanov SS; Bolieva LZ; Sozaeva MS; Zhuchkova SM; Gimaldinova NE; Sidukova EE; Asoskova AV; Mumladze RB
    Mol Biol Rep; 2019 Jun; 46(3):2761-2769. PubMed ID: 30850966
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Renal function and plasma dabigatran level measured at trough by diluted thrombin time assay].
    Martinuzzo ME; Duboscq C; Viñuales ES; Girardi B; Penchasky D; Ceresetto J; Stemmelin G; Otero V; Barrera LH; López MS; Otaso JC; Hoyhamburu J
    Medicina (B Aires); 2017; 77(1):31-36. PubMed ID: 28140308
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An open-label study of the pharmacokinetics and pharmacodynamics of dabigatran etexilate 150mg once daily in Caucasian patients with moderate renal impairment undergoing primary unilateral elective total knee or hip replacement surgery.
    Eriksson BI; Mikuska Z; Feuring M; Amiral J; Haertter S; Stangier J; Nehmiz G; Weitz JI
    Thromb Res; 2016 Aug; 144():158-64. PubMed ID: 27352238
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.